The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / August / Toxoplasmosis: The Neglected Eye Threat
Health Economics and Policy Research & Innovations News

Toxoplasmosis: The Neglected Eye Threat

Global team urge WHO to formally recognize toxoplasmosis as a neglected tropical disease

8/18/2026 4 min read

Share

  • Full Article
  • Summary
  • Report
  • Poll

Clinical Report: Toxoplasmosis: The Neglected Eye Threat

Overview

A group of experts advocates for the recognition of toxoplasmosis as a neglected tropical disease (NTD) by the WHO, emphasizing its significant impact on vision health.

Background

Toxoplasmosis is the leading cause of intraocular infection globally and a major contributor to visual impairment and blindness. The condition is often underrepresented in research and policy, despite its significant burden on affected populations.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • Toxoplasmosis meets WHO criteria for NTD designation due to its disproportionate burden on impoverished populations.
  • Congenital toxoplasmosis can lead to severe neurological and visual impairments.
  • Preventive measures include safer food handling, improved sanitation, and maternal screening.
  • Toxoplasmosis receives less research funding per disability-adjusted life-year (DALY) compared to other NTDs.

Clinical Implications

Healthcare professionals should be aware of the significant impact of toxoplasmosis on vision health.

Conclusion

The case for recognizing toxoplasmosis as an NTD is compelling.

Related Resources & Content

  1. Furtado J.M. et al., PLOS Neglected Tropical Diseases, 2026 -- Toxoplasmosis meets the World Health Organization criteria for a neglected tropical disease
  2. Frontiers in Pediatrics — Atypical congenital toxoplasmosis presenting with neonatal jaundice and central nervous system involvement: a case report and therapeutic challenges to limited access to first-line anti-toxoplasma medications
  3. Retinal Physician — Ocular Toxoplasmosis as the Presenting Sign of AIDS
  4. the ophthalmologist — Ocular Toxoplasmosis Review
  5. new retinal physician — Atypical Ocular Toxoplasmosis Manifesting as Acute Retinal Necrosis
  6. Clinical Care of Toxoplasmosis | Toxoplasmosis | CDC
  7. Toxoplasma gondii Encephalitis: Adult and Adolescent OIs | NIH
  8. THE WHO STRATEGIC AND TECHNICAL ADVISORY GROUP FOR NEGLECTED TROPICAL
  9. Toxoplasmosis meets the World Health Organization criteria for a neglected tropical disease | PLOS Neglected Tropical Diseases
  10. Controversy and consensus on the management of ocular toxoplasmosis: A joint statement by the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII), the Asia-Pacific Vitreo-Retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and The Infectious Uveitis Treatment Algorithm Network (TITAN) Group - ScienceDirect
  11. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis - PubMed
  12. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis - PubMed
  13. Treatment Protocols for Gestational and Congenital Toxoplasmosis: A Systematic Review and Meta-Analysis - PMC

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: